News & Updates
Filter by Specialty:
Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae
Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.
Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae
18 Sep 2022
Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.
Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
16 Sep 2022
Smoking during surgical mask use may impair vascular function
Smoking during prolonged use of surgical facemasks due to the COVID-19 pandemic may further compromise vascular function, a study has shown.
Smoking during surgical mask use may impair vascular function
16 Sep 2022
MRNA booster shot durably bolsters defenses against severe COVID-19
Boosting with an mRNA vaccine yields significant protection against severe COVID-19 and may keep people out of the hospital for up to 6 months, as shown in a Singapore study.
MRNA booster shot durably bolsters defenses against severe COVID-19
14 Sep 2022
Ivermectin not superior to placebo in mild COVID-19
Early treatment with single- or double-dose ivermectin is no better than placebo in avoiding progression to hospitalization and in improving symptoms in mild COVID-19, results of a study have shown.
Ivermectin not superior to placebo in mild COVID-19
13 Sep 2022
Nirmatrelvir conferred protection in older adults during the Omicron outbreak
During the surge of the Omicron (B.1.1.529) variant, antiviral therapy with nirmatrelvir significantly reduced the rate of COVID-19-related hospitalization or death among patients aged ≥65 years, according to a recent study.